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Abstract
Background: Exosomes isolated from plasma of patients with sepsis may induce vascular apoptosis and myocardial
dysfunction by mechanisms related to inflammation and oxidative stress. Despite previous studies demonstrating
that these vesicles contain genetic material related to cellular communication, their molecular cargo during sepsis is
relatively unknown. In this study, we evaluated the presence of microRNAs (miRNAs) and messenger RNAs (mRNAs)
related to inflammatory response and redox metabolism in exosomes of patients with septic shock.
Methods: Blood samples were collected from 24 patients with septic shock at ICU admission and after 7 days of
treatment. Twelve healthy volunteers were used as control subjects. Exosomes were isolated by ultracentrifugation,
and their miRNA and mRNA content was evaluated by qRT-PCR array.
Results: As compared with healthy volunteers, exosomes from patients with sepsis had significant changes in 65
exosomal miRNAs. Twenty-eight miRNAs were differentially expressed, both at enrollment and after 7 days, with
similar kinetics (18 miRNAs upregulated and 10 downregulated). At enrollment, 35 differentially expressed miRNAs
clustered patients with sepsis according to survival. The pathways enriched by the miRNAs of patients with sepsis
compared with control subjects were related mostly to inflammatory response. The comparison of miRNAs from
patients with sepsis according to hospital survival demonstrated pathways related mostly to cell cycle regulation. At
enrollment, sepsis was associated with significant increases in the expression of mRNAs related to redox
metabolism (myeloperoxidase, 64-fold; PRDX3, 2.6-fold; SOD2, 2.2-fold) and redox-responsive genes (FOXM1, 21-fold;
SELS, 16-fold; GLRX2, 3.4-fold). The expression of myeloperoxidase mRNA remained elevated after 7 days (65-fold).
Conclusions: Exosomes from patients with septic shock convey miRNAs and mRNAs related to pathogenic
pathways, including inflammatory response, oxidative stress, and cell cycle regulation. Exosomes may represent a
novel mechanism for intercellular communication during sepsis.
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Background
Sepsis is one of the leading causes of death in intensive
care units (ICUs) worldwide. It represents a difficult
challenge to the intensivist because this condition lacks
good diagnostic tools and adequate evidence-based
treatments. The incidence of sepsis has increased con-
siderably in recent years, and the morbidity and mortal-
ity rates associated with the syndrome are extremely
high, especially for septic shock, in which mortality
ranges from 40% to 60% in different populations [1–4].
The molecular basis underlying sepsis mechanisms
are complex and still only partially understood [5].
Studies have demonstrated that the pathophysiology of
sepsis is related to a dysregulated inflammatory re-
sponse and oxidative stress [6]. Recently, the presence
of circulating extracellular vesicles (EV) shed from dif-
ferent cell types during sepsis and their relationship
with sepsis pathophysiology was established [7–9]. Pre-
vious studies demonstrated that a special type of EV,
named exosomes and mostly originated from platelets,
induce superoxide production and apoptosis in vascular
cells during sepsis by inflammatory and redox mecha-
nisms [10, 11]. Also, our group established a correlation
between exosomes and organ dysfunction by demon-
strating exosome-induced myocardial depression in iso-
lated heart and papillary muscle preparations. This
dysfunction was mediated by a mechanism associated
with myocardial nitric oxide production [12].
Recent studies demonstrated that exosomes may play
a role in cell-to-cell communication in normal physi-
ology and several diseases, including cancer, through
carriage of functional messenger RNA (mRNA) and
microRNAs (miRNAs, miRs) [13–15]. Even though the
presence of miRNAs in plasma during sepsis was previ-
ously demonstrated [16, 17], the genetic content of exo-
somes during sepsis was evaluated in very few studies
[18–20].
In the present pilot study, we isolated exosomes from
plasma of patients with septic shock and analyzed their
entire miRNA content. We also assessed mRNAs, specif-
ically looking for those related to inflammatory response
and oxidative stress, because previous studies by our
group and others demonstrated that these mechanisms
mediate the effect of exosomes during sepsis [10, 11]. In
addition, we correlated the differential expression of
miRNA to outcomes and used pathway enrichment ana-
lysis to elucidate their most important possible biological
mechanisms. miRNA profiling revealed that the genetic
material contained in exosomes from patients with sep-
sis is related to modulation of immune system and cell
cycle regulation. The data presented in this article may
help to generate new insights into sepsis pathophysi-
ology and ultimately provide research windows to devel-
opment of novel therapies.
Methods
A detailed description of the methods is provided in
Additional file 1.
Patients and control subjects
In this prospective observational study, we recruited 24
patients in the initial 24 h of a first episode of septic
shock who were admitted to the ICUs of Hospital Sirio-
Libanes, Hospital São Paulo/Federal University of São
Paulo, and Hospital das Clinicas/University of São Paulo,
all in São Paulo, Brazil, from March 2012 to August
2013. Septic shock was defined as the need for vasopres-
sor support after adequate fluid resuscitation [21]. We
excluded patients with severe anemia (hemoglobin < 7.0
g/dl) or active bleeding, those with known platelet disor-
ders or conditions that cause thrombocytopenia other
than sepsis (e.g., heparin-induced thrombocytopenia or
chemotherapy), those with full heparin use (low molecu-
lar weight heparin or unfractionated) or use of any other
medications that interfere with platelet function, those
with a life expectancy no longer than 24 h, and patients
with active cancer. The included patients had 30-ml
blood samples collected from a central venous or arterial
catheter up to 24 h after ICU admission (D0) and from a
central venous or arterial catheter or by peripheral punc-
ture 7 days after treatment (D7) for those who survived
or were not discharged from the hospital. Twelve
healthy volunteers without comorbidities and paired in a
2:1 ratio for sex and age were used as control subjects.
The study was approved by the institutional ethics and
review board of Hospital Sirio-Libanes (Comitê de Ética
em Pesquisa, protocol number HSL 2010/61), which
served as the coordinating institution, and also from the
other institutions (Comitê de Análise para Projetos de
Pesquisa, Hospital das Clinicas, Universidade de São
Paulo, and Comitê de Ética em Pesquisa, Universidade
Federal de São Paulo). Informed consent was obtained
from the patients or their representatives.
Isolation and characterization of exosomes
Plasma was filtered through 0.2-μm membranes; exo-
somes were isolated by ultracentrifugation as previously
described [12]; and protein extracts were assessed by
Western blotting using antibody against exosomal
flotillin-1 (ab41927; Abcam, Cambridge, UK). For valid-
ation, the number of particles and the particle size were
measured using a nanoparticle-tracking analysis device
(NanoSight LM10; Malvern Panalytical, Malvern, UK)
coupled to a charge-coupled device camera and a laser
emitting a 60-mW beam at 405 nm. Video acquisitions
were performed in five recordings of 60 seconds each.
At least 1000 particles were tracked in each sample.
Nano flow cytometry was carried out using human anti-
bodies against cell surface antigens CD9 (exosome
Real et al. Critical Care  (2018) 22:68 Page 2 of 11
marker) and CD41 (platelet marker) using a CytoFLEX
flow cytometer (Beckman Coulter Life Sciences, Indian-
apolis, IN, USA). We used violet side scatter and fluores-
cent polystyrene beads (Megamix-Plus FSC and SSC;
BioCytex, Marseille, France) with known sizes (100, 160,
200, 240, 300, 500, and 900 nm) to identify vesicles
smaller than 1 μm. The analysis was performed using
CytExpert 2.1 software (Beckman Coulter Life Sciences).
Plasmatic concentrations of interleukin (IL)-1β, IL-6, IL-
8, IL-10, IL-13, tumor necrosis factor-α, and transform-
ing growth factor-β were measured in seven patients
with sepsis by enzyme-linked immunosorbent assay.
miRNA profiling and inflammatory and oxidative stress
gene expression analysis
RNA and miRNA were extracted using the miRNeasy
Mini Kit (Qiagen, Valencia, CA, USA) and were reverse-
transcribed into complementary DNA (cDNA). Using
TaqMan® Array Microfluidic Cards technology (Applied
Biosystems/Thermo Fisher Scientific, Foster City, CA,
USA) and qRT-PCR, we simultaneously evaluated 754
mature miRNAs (TaqMan MicroRNA Array v3.0; Life
Technologies/Thermo Fisher Scientific, Grand Island,
NY, USA) and 90 genes related to immune response
(TaqMan Low Density Array Immune Profiling; Life
Technologies/Thermo Fisher Scientific). The oxidative
stress study consisted of 84 genes associated with oxida-
tive stress and antioxidant defense using a commercial
PCR array (PAHS065-A; Qiagen). Raw data were ana-
lyzed using ExpressionSuite v1.0.3 software (Life Tech-
nologies/Thermo Fisher Scientific), and all cycle
threshold (Ct) values were evaluated using StatMiner
version 5 (Integromics, Granada, Spain). Considering the
cDNA preamplification step, Ct values greater than or
equal to 32 for miRNAs and oxidative stress and greater
than or equal to 35 for the immune study were excluded
according to the manufacturers’ instructions.
For the miRNA analysis, the geNorm method was
used to identify the best reference controls. A median of
miR-17, miR-20a, and miR-106a expression was then
used for data normalization. The expression levels of im-
mune and stress oxidative genes were normalized to 18S
ribosomal RNA and β-actin, respectively [22]. The rela-
tive gene expression data were calculated using the com-
parative cycle threshold (2−ΔΔCt) method [23].
Target prediction, network pathway analysis, and cluster
analysis
Ingenuity Pathway Analysis (IPA) software (www.ingen-
uity.com; Qiagen Bioinformatics, Redwood City, CA,
USA) and the MicroRNA Target Filter software tool
(Qiagen Bioinformatics), which relies on three algo-
rithms (TargetScan, TarBase, and miRecords), were used
to identify putative targets of the miRNAs differentially
expressed in septic exosomes versus healthy controls
and in the comparison of patients with sepsis according
to survival. IPA Network maintains a graphical database
of networks of interacting genes (Ingenuity Knowledge
Base; Qiagen Bioinformatics). Only experimentally vali-
dated targets were selected, indicating that only net-
works already demonstrated in previous studies to be
associated with the specific miRNA expression are
shown. A list containing the differentially miRNAs was
uploaded into the IPA software and analyzed on the
basis of content as of October 2016. The significance of
the association between each list and the canonical path-
ways was measured by Fisher’s exact test. As a result, a p
value was obtained, and values below 0.05 were consid-
ered significant. To build the figures, molecules were
represented as nodes, and the biological relationship be-
tween two nodes was represented as a line. These con-
nections were supported by at least one reference from
the literature, from a textbook, or from canonical infor-
mation stored in the database [24].
Using the normalized 2−ΔΔCt values, we constructed
heat maps for comparison of patients with sepsis with
healthy control subjects and patients with sepsis accord-
ing to outcome, where the colors represent a scale of the
smaller (blue) to larger (red) expression ratios for each
miRNA as compared with the control samples (value =
1/white color). A further analysis by hierarchical cluster
based on Euclidean correlation was then done. Each row
represents a miRNA, and each column represents a pa-
tient sample. The color scale shown in the cluster
grouping illustrates the normalized 2−ΔΔCt values for the
miRNAs for all samples, where red and blue represent
the expression above or below the average, respectively.
Statistical methods
The statistical tests were applied only to targets
expressed in at least 50% of the samples from each
group. The 2−ΔΔCt values were tested for normal distri-
bution using the Shapiro-Wilk test. For both paired and
nonpaired comparisons, the Wilcoxon test was used.
Benjamini-Hochberg adjustment was used to correct p
values (p < 0.05) for false discovery rates [24]. All tests
were performed using R software version 3.1.2 (R Foun-
dation for Statistical Computing, Vienna, Austria).
Results
Patients’ characteristics and outcomes
Of the 24 patients with septic shock, 18 had blood sam-
ples collected both at enrollment and 7 days after. Table 1
shows the main characteristics of the patients. Our pa-
tients were relatively younger and with few comorbidities.
The organ support at study enrollment was substantial,
since 67% of them were mechanically ventilated and all
patients were receiving norepinephrine. All but two
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patients received prophylactic heparin (unfractionated or
low molecular weight) during the study period. Red blood
cell transfusion was administered to six patients after 2 (1-
5) days of inclusion. Two patients received fresh frozen
plasma and one patient received platelet transfusion on
day one before collection of study samples. The antibiotics
most used were ceftriaxone (11 patients), vancomycin (9
patients), meropenem (7 patients), metronidazole (4 pa-
tients), piperacillin-tazobactam (4 patients). Other four
different antibiotics were also used. Hospital mortality rate
was 35%. Healthy volunteers had mean age of 49.7 ± 9.6
years and were predominantly male (58%). None of them
reported previous use of medications.
Characterization of exosomes
The EV isolated from plasma were evaluated by im-
munoblotting. We observed the expression and quantifi-
cation of flotillin-1, a membrane-associated protein
involved in endocytosis and an exosomal marker [25]
(Additional file 1: Figure S1a and b). The RNA content
was enriched mainly by miRNAs and RNAs in the size
range of 19–400 nucleotides (Additional file 1: Figure
S1c). Further analysis with NanoSight in three patients
with paired samples collected at both time points dem-
onstrated a size range predominantly from 90 to 150 nm
(Additional file 1: Figure S1d), which is mostly consist-
ent with exosomes.
The analysis of flow cytometry experiments demon-
strated that a significant portion of vesicles was positive
for CD9 and CD41 in both patients with sepsis and
healthy volunteers, suggesting an exosomal and platelet
origin for these vesicles (Additional file 1: Figure S2).
Taken together, our results strongly suggest that the
major component of our vesicle pool was composed of
platelet-derived exosomes. Plasmatic concentrations of
cytokines were below the detection limit of the method
for the majority of the patients, except for IL-6 measure-
ment in three patients (data not shown).
Sepsis significantly alters the circulating exosomal miRNA
profile
To test the hypothesis that sepsis alters the expression
of exosomal miRNAs, we first performed miRNA profil-
ing analysis in patients with sepsis at enrollment and
Table 1 Demographic data of the included patients
Characteristics All patients (N = 24)
Male sex, n (%) 14 (61)
Age, years 53 ± 17
Comorbidities, n (%)
Arterial hypertension 3 (13)
Diabetes mellitus 5 (21)
Tobacco use 2 (10)
Others 3 (13)
Origin of patients, n (%)
Emergency room 12 (50)
Ward 5 (21)
Operating room 7 (29)
Source of sepsis, n (%)
Lung 7 (28)
Urinary 5 (21)
Abdominal 5 (21)
Other sources 5 (21)
Undetermined 2 (8)
Hemodynamic data
Norepinephrine dosage D0, μg/kg/minute 0.3 (0.1–0.5)
Lactate D0, mg/dl 22 (18–36)
Mean arterial pressure D0, mmHg 70 (63–78)
Ventilatory data
Use of mechanical ventilation D0, n (%) 16 (67)
Tidal volume D0, ml 500 ± 88
PEEP D0, cmH2O 8 ± 2.7
Fraction of inspired oxygen 0.4 ± 0.17
Peripheral oxygen saturation D0, % 96 ± 2
Duration of mechanical ventilation, days 3 (2.25–7)
Hematologic and inflammatory data
Leukocytes D0, cells/mm3 18,974 ± 9790
Leukocytes D7, cells/mm3 13,270 ± 6262
Hemoglobin D0, g/dl 10.4 ± 1.6
Hemoglobin D7, g/dl 9.7 ± 1.7
Platelets D0, 103 cells/mm3 185 ± 134
Platelets D7, 103 cells/mm3 261 ± 114
CRP D0 (n = 18), mg/dl 290 (212–327)
CRP D7 (n = 17), mg/dl 51 (30–125)
Procalcitonin D0 (n = 9), ng/ml 15.7 (2–22.4)
SAPS3 score 57.7 ± 6.2
SOFA score D0 8.4 ± 3.3
SOFA score D7 1.7 ± 3.8
Table 1 Demographic data of the included patients (Continued)
Characteristics All patients (N = 24)
ICU length of stay, days 5 (4–7.75)
Hospital length of stay, days 13.5 (8–22.5)
Hospital mortality, n (%) 8 (35)
Abbreviations: PEEP Positive end-expiratory pressure, CRP C-reactive protein,
SAPS3 Simplified Acute Physiology Score III, SOFA Sequential Organ Failure
Assessment, ICU Intensive care unit
Data are expressed as number (%), mean ± SD, or median
(25th–75th percentile)
Real et al. Critical Care  (2018) 22:68 Page 4 of 11
after 7 days and compared the results with those in
healthy individuals (Additional file 1: Table S1). Thirty
miRNAs were differentially expressed at enrollment as
compared with controls. After 7 days, 65 miRNAs were
differentially expressed between the sepsis and control
samples. Twenty-eight miRNAs were commonly
expressed at both time points (at enrollment and 7 days
later). Figure 1 demonstrates that theses 28 miRNAs
expressed at both time points maintained the same ex-
pression kinetics during the disease course (18 upregu-
lated and 10 downregulated). Hierarchical clustering was
performed for all samples considering the 65 differen-
tially expressed miRNAs in sepsis. On the basis of
miRNA expression values, samples from each group
(septic and control) partially clustered together
(Additional file 1: Figure S3). Regarding patients who
had two samples collected during intensive care treat-
ment, no miRNAs were differentially expressed between
D0 and D7 (Wilcoxon paired-samples test). To gain
insight into the biological significance of the global or
system-level impacts of the differentially expressed miR-
NAs in exosomes in sepsis, IPA software was used to
identify potential mRNA targets of the differentially
expressed miRNAs. Considering only previously demon-
strated targets of the miRNAs described here, 473 and
817 targets were identified at D0 and D7, respectively.
The canonical pathways modulated by exosomal miR-
NAs at these two time points are mostly related to in-
flammatory and immune responses (Fig. 2). A schematic
figure of IL-6 signaling canonical pathways showing the
miRNAs differentially expressed in our study, as well as
their targets, is shown in Additional file 1: Figure S4.
Differential miRNA expression in patients with sepsis
according to outcomes
To identify circulating miRNAs that could be related to
clinical outcome, we further investigated the samples col-
lected from patients with sepsis at ICU admission and an-
alyzed their miRNA expression according to hospital
outcomes. The unsupervised hierarchical clustering ana-
lysis (Fig. 3) showed a partial separation based on the ex-
pression of 35 miRNAs (Additional file 1: Table S2) of the
patients who survived versus those who died of sepsis.
Enrichment pathway analysis was also performed to
identify targets for these 35 differentially expressed sep-
tic exosomal miRNAs. We identified 275 specific experi-
mentally validated cellular targets of these miRNAs.
Differently from the comparison to healthy volunteers,
the canonical pathways possibly influenced by these
miRNAs were predominantly related to processes in-
volving cell cycle regulation (Fig. 4). A schematic figure
of cell cycle regulation and miRNAs that modulate it is
provided in Additional file 1: Figure S5.
Analysis of mRNAs related to inflammatory response
To evaluate whether mRNAs related to immune response
were present in exosomes, we compared the expression of
90 immune/inflammation-related genes by qPCR using
the RNA isolated from patients with sepsis at enrollment
and after 7 days and from healthy individuals. We could
not detect significant amplification of many of the im-
mune/inflammation-related genes in the control group, so
evaluation of patients with sepsis versus control subjects
was not possible. However, considering a paired compari-
son of patients with sepsis between enrollment and 7-day
samples, we observed that chemokine (C-C motif) ligand
5/regulated on activation, normal T cell expressed and
Fig. 1 Exosomal RNA profile during sepsis. Venn diagram shows
the number of microRNAs (miRs) from patients with sepsis at
ICU admission (D0) and after 7 days (D7) as compared with
those of healthy control subjects. The heat map illustrates the
fold change profile of the 28 microRNAs differentially expressed
at both time points
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secreted expression was 4.5-fold higher at the seventh day
(p = 0.009; Wilcoxon paired-samples test).
Exosomes from patients with sepsis contain mRNA
related to redox signaling
As shown in Fig. 5, we also investigated the expression of
84 mRNAs related to antioxidant defenses and oxidative
stress in exosomes from patients with sepsis and healthy
control subjects. As compared with healthy volunteers,
patients with sepsis at enrollment had an increased ex-
pression of mRNAs of myeloperoxidase (MPO) (66-fold),
the antioxidant enzyme peroxiredoxin 3 (2.6-fold), the
mitochondrial enzyme superoxide dismutase 2 (2.2-fold),
and the following oxidative stress response genes: Fork-
head box protein M1 (FOXM1) (21-fold), selenoprotein S
(16-fold), and glutaredoxin 2 (3.4-fold). After 7 days (D7),
only MPO mRNA expression remained upregulated as
compared with the control group (65-fold). There was no
differentially expressed mRNA in the comparison of pa-
tients with sepsis between enrollment and 7 days later.
Discussion
Our study comprehensively assessed the profile of miR-
NAs and mRNAs of exosomes from patients with septic
shock in two stages of treatment. We demonstrated a
differential regulation of miRNAs during sepsis, and the
analysis of their targets indicates that they may poten-
tially influence the immune system. Interestingly, the
same pathways are still modified after 7 days of ICU ad-
mission, when most patients were already in a clinical
recovery phase, as suggested by their reduced Sequential
Organ Failure Assessment score. Our results suggest a
subclinical and prolonged inflammatory response in sep-
sis, as previously reported in severe community-acquired
pneumonia [26].
Earlier data demonstrated the role of miRNAs in the
inflammatory/immune response in sepsis [27] and
trauma. A study in which researchers analyzed the
miRNA profiles of ten patients with polytrauma identi-
fied some miRNAs that were also differentially expressed
in our patients (hsa-let-7b-5p, hsa-miR-151a-3p, hsa-
Fig. 2 Biological pathways potentially influenced by differentially expressed microRNAs carried by exosomes of patients with septic shock
at intensive care unit admission and 7 days later compared with those of healthy individuals. NF-kB Nuclear factor-κB, PPAR Peroxisome
proliferator-activated receptor, IL Interleukin
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miR-16-5p, hsa-miR-186-5p, hsa-miR-221-3p, hsa-miR-
25-3p, hsa-miR-28-5p, hsa-miR-340-3p, and hsa-miR-
618) [28]. This could indicate a similar response of the
body to a serious infectious or inflammatory injury.
Very few previous studies demonstrated the presence of
miRNAs in exosomes during sepsis. In a mouse model,
miRNA-125b was identified in endothelial progenitor cell-
derived exosomes, and sepsis induced a downregulation of
this miRNA [19]. In our study, miRNA-125b showed
greater expression in patients with sepsis with persistent
expression after 7 days. In another study, some miRNAs
from endothelial progenitor cell-derived exosomes (miR-
15a, miR-27a, and miR-34a) had differential expression in
plasma of patients with sepsis [18]. In our study, the ex-
pression of exosomal miR-27a was six times higher among
sepsis survivors. These miRNAs modulate the inflamma-
tory response and the cell cycle [18], a finding similar to
that derived from our analysis.
Whereas the comparison between sepsis and controls
identified miRNAs predominantly related to inflammation,
the evaluation regarding outcomes identified miRNAs
mostly related to cell cycle modulation. Cell cycle modula-
tion was described in the context of sepsis and acute kid-
ney injury [29–31] and correlated with miRNA regulation
[29, 32]. In this scenario, miRNA regulation of target genes
may lead the reentry into the proliferative cell cycle and
differentiation, such as in fibrotic repair responses follow-
ing tissue injury [33], or, more likely, miRNAs may regulate
cell cycle arrest to prevent differentiation of damaged cells
under hostile conditions [34, 35]. Whether it is conceivable
that the miRNAs described here may affect both mecha-
nisms, it is not possible without functional studies or on
the basis of our results to identify which pathways are
more influenced by these miRNAs.
The evaluation of mRNA related to oxidative stress dem-
onstrated a significant and persistent increase in MPO
mRNA. One major pathway regulated by MPO is the deg-
radation of melatonin [36], which is reduced during sepsis,
with MPO playing a role in this process [37, 38]. Another
mRNA identified is FOXM1, a transcription factor related
to cell cycle progression and activated by oxidative stress
[39]. Overexpression of FOXM1 in septic mice protects
Fig. 3 Patterns of microRNA (miR) expression from exosomes of patients with septic shock at enrollment (D0), comparing hospital survivors (gray
bars) and nonsurvivors (black bars). The figure shows the analysis by hierarchical clustering of samples considering the change in cycle threshold
values after filtering and normalization of data
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against lung injury and increases survival [40, 41]. In our
study, the increase in FOXM1 mRNA could also indicate a
mechanism related to cell cycle regulation.
There is a paucity of information on how exosomal
miRNAs interact with their targets to produce their ef-
fects. Most authors agree that exosomes are efficient car-
riers of proteins and genetic material to neighboring or
more distant cells. However, the mechanisms of exo-
some–recipient cell interaction are unclear. The inter-
action usually starts with exosome internalization by
various proposed pathways, including clathrin-mediated
endocytosis, phagocytosis, or macropinocytosis [42].
Once in the recipient cell, exosomal miRNA and mRNA
are usually functional and can interact with their targets
to synthesize new proteins or modulate gene expression
[13]. This has been demonstrated mostly in laboratory
cell lines but not in sepsis, so any assumption regarding
the interplay between exosomal genetic content and tar-
get cells during sepsis would be speculative.
Our study has limitations worth mentioning. First,
this is an exploratory study with a small number of pa-
tients included, so our findings should be considered
hypothesis-generating. Also, several comparisons were
made, and as such, our analysis was corrected with a
multiple correction-specific test (Benjamini-Hochberg)
to minimize false-positive results. We included only pa-
tients in the first episode of sepsis to avoid those with
chronic inflammation or immunosuppression that
could influence the results. This criterion may limit the
generalizability of our findings. Because we did not
quantify the number of exosomes in the plasma of pa-
tients and healthy volunteers, the effect of sepsis on the
exosomal counts was not estimated, and we could not
normalize exosomal miRNA and mRNA levels to the
amount of plasma exosomes. Plasmatic concentrations
of cytokines were below the detection limit of the
method in our patients, probably owing to the long-
term storage of these samples, so we could not correl-
ate the results of inflammatory cytokines with the
exosomal genetic content. Also, we assessed only
mRNA related to inflammatory response and oxidative
stress, because these two important mechanisms were
previously demonstrated to mediate the effects of exo-
somes in sepsis [11, 12]. With this approach, it was not
possible to evaluate other pathophysiological targets of
exosomal mRNA. In order to compare the effects of in-
fectious and noninfectious injury, we did not include a
control group composed of noninfected ICU patients.
Fig. 4 Enriched canonical pathways regulated by expressed microRNAs (miRNAs) in exosomes of patients with sepsis at enrollment according to
hospital outcome. Ratios refer to the number of genes in the miRNA target list of a specific time point over the total number of genes in the
respective canonical pathway. TGF-β Transforming growth factor-β, ILK Integrin-linked kinase, BTG B cell translocation gene
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In addition, we did not evaluate the function of these
miRNAs in sepsis, so the pathways that they influence
were not demonstrated in this study.
Conclusions
Exosomes from patients with sepsis convey genetic ma-
terial that may be related to key pathways in the patho-
genesis of sepsis, including inflammatory response,
oxidative stress, and cell cycle regulation. Further func-
tional studies are required to clarify the exact contribu-
tion of these vesicles to the exchange of genetic material
and intercellular communication during sepsis.
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days later) versus healthy control subjects. * Unadjusted p value < 0.001; adjusted p value = 0.003. # Unadjusted p value < 0.001; adjusted p value
= 0.008. $ Unadjusted p value = 0.001; adjusted p value = 0.03. @ Unadjusted p value = 0.004; adjusted p value = 0.04. ¶ Unadjusted p value =
0.005; adjusted p value = 0.04. § Unadjusted p value < 0.001; adjusted p value = 0.01. Ψ Unadjusted p value = 0.007; adjusted p value = 0.05.
Unadjusted p value refers to Wilcoxon test. Adjusted p value refers to Benjamini-Hochberg correction for multiple comparisons. n = 21 for sepsis
D0; n = 16 for sepsis D7; and n = 10 for controls. MPO Myeloperoxidase, FOXM1 Forkhead box protein M1, SELS Selenoprotein S, GLRX2 Glutare-
doxin 2, PRDX3 Peroxiredoxin 3, SOD2 Superoxide dismutase 2
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